One command center.
Zero blind spots.

Compliance monitoring is the ongoing review of field activity against policy. Compliance intelligence adds an AI layer on top of that: it reads monitoring results, investigation context and historical findings to surface emerging risk and recommend next steps, so a compliance team moves from detection to resolution instead of just producing more reports.

AI runs across five points in the workflow: risk detection, which flags anomalies and patterns; investigation, which summarizes findings and context; insights, which turns results into trends and executive reporting; the Compliance Co-Pilot, which answers policy and regulatory questions; and resolution, which recommends next steps. It's built into each stage of the workflow, not offered as a separate add-on.

Compliance monitoring software gives a compliance team one place to plan, execute and close out ongoing review of field activity like speaker programs, advisory boards and rep interactions. qordata's Compliance Central replaces manual spot checks with a risk-based annual plan, standardized checklists and a remediation workflow, closing the oversight gaps that let violations go unnoticed until an audit.

Yes. qordata's Compliance Central scores every speaker across payment volume, prescribing data (TRx), program frequency and territory, using custom weightings to produce a risk score and profile. The highest-risk profiles are routed to a dedicated workbench where compliance teams review the underlying data and take follow-up action, so attention goes to the speakers most likely to draw regulatory scrutiny instead of reviewing everyone equally.

In a 2020 Special Fraud Alert, the OIG flagged speaker programs as a heightened fraud and abuse risk, citing features such as high payments, repeat attendees, thin educational content, and alcohol or expensive meals. Monitoring speaker activity against defined, documented criteria is now a standard expectation in a life sciences compliance program, and it's exactly what qordata's Compliance Central is built to track.

Yes. qordata's Compliance Central syncs programs, rosters and presentations directly from Veeva and pulls employee data, advisory boards and national exhibit data through FTP feeds, with real-time sync so monitoring reflects what is happening in the field, not a stale export from last month. The strongest platforms integrate with CRM and event systems this way instead of reconciling field activity manually.

In qordata's Compliance Central, flagged issues become tracked corrective-action tasks in a remediation module, with owners, comments, attachments and status visible on a live dashboard. A good remediation workflow lets teams create and assign tasks tied to monitoring findings, track resolution, and keep a real-time view of progress for audit purposes, so findings end as resolved, documented outcomes instead of sitting in a spreadsheet nobody revisits.

Yes. qordata's Compliance Central runs 14 standardized checklists that track planned versus actual activity across every monitored event. Planned activities are what the annual plan schedules for a period; actual activities are what was executed and logged, and tracking both side by side surfaces gaps between what should have happened and what did. Full roster and historical monitoring and remediation records also support trend analysis and let a team answer an audit or regulator question at any point without reconstructing the picture. That gives a compliance team a documented answer, not a narrative, when asked whether the plan was executed.

qordata's Compliance Central runs live Field Sales, Events and Monitoring dashboards, covering overall monitoring progress, field sales activity and monitored events like speaker programs and advisory boards, alongside automated email alerts and task status notifications for monitoring and remediation updates. Reviewers and leadership see issues as they surface, without manual status checks or waiting for a quarterly report to catch up.

Yes. qordata's Compliance Co-Pilot answers natural-language compliance questions and can reference your own uploaded policy documents or benchmark against published guidance such as the PhRMA Code, OIG guidance and speaker program alerts, the Sunshine Act, Stark Law, the Anti-Kickback Statute and CMS federal and state rules. A compliance manager gets a sourced answer inside the workflow that reflects the company's own rules, not just industry standards.

No. An annual monitoring plan defines the objectives, calendar and scope of monitoring for the year, aligned with the company's compliance risk priorities, so effort is planned rather than reactive. In qordata, the plan in Compliance Central is configured directly from the risk assessment results, so the year's objectives and calendar align with calibrated risk priorities instead of starting from a blank page or last year's guesswork.

Leading options include real-time platforms such as qordata's Compliance Central, which track and audit interactions between life sciences companies and healthcare professionals, such as speaker programs, advisory boards, and field activities, against a company's monitoring plan, flagging risk in real time rather than retrospectively.

Speaker programs, advisory boards, and other HCP-facing field events typically need ongoing monitoring against planned vs. actual activity, using standardized checklists so nothing falls outside a company's monitoring plan.

Rosters document who actually attended a speaker program, advisory board, or other monitored event. Being able to upload and track rosters without volume limits keeps attendee records consistent and audit-ready across every monitored activity.

Real-time monitoring is the main alternative, giving compliance teams live visibility into field activity and risk as it happens rather than reconstructing a picture only after an audit request comes in. qordata's Compliance Central is built around this real-time model.

Some teams rely on ad hoc, reviewer-by-reviewer judgment instead, but this tends to produce inconsistent monitoring quality across activities. Standardized checklists, qordata's Compliance Central uses 14, keep planned-versus-actual tracking consistent across every monitored activity type rather than leaving each reviewer to define their own criteria.

Advisory boards are generally tracked the same way as speaker programs, through real-time dashboards and planned-versus-actual monitoring, because consulting and advisory arrangements can raise similar Anti-Kickback Statute questions when payments exceed fair market value or the real purpose is to influence prescribing.

By monitoring HCP engagement and spend-related field activity in real time and maintaining full historical records, ongoing compliance monitoring helps ensure the underlying data feeding Sunshine Act reporting stays accurate and audit-ready throughout the year rather than only at year-end.

Yes. Compliance monitoring needs are common across life sciences organizations broadly, covering pharmaceutical and medical device companies alike.

The OIG's 2020 Special Fraud Alert on speaker programs flags features that signal inherent Anti-Kickback Statute risk, such as repeat attendance, expensive meals or alcohol, thin educational content, and speaker selection based on prescribing, which suggest the real purpose is to induce prescribing rather than to educate. Advisory boards raise similar questions when payments or attendance lack a legitimate purpose. Risk-based speaker scoring and a remediation workflow are designed to help surface exactly these warning signs.

Under a 2010 amendment to the Anti-Kickback Statute, a claim that includes items or services resulting from an Anti-Kickback Statute violation constitutes a false claim for purposes of the False Claims Act. This link is why compliance monitoring of HCP engagement activity functions as a false-claims risk-reduction measure, not just an Anti-Kickback Statute compliance exercise.

Off-label promotion is marketing a drug or device for a use, population, or dosage that hasn't been approved by the FDA. It's prohibited under the Food, Drug, and Cosmetic Act for a company to promote off-label, even though physicians may legally prescribe off-label based on their own clinical judgment. Compliance monitoring programs typically review speaker program content and field materials to confirm messaging stays within FDA-approved labeling, an area overseen by the FDA's Office of Prescription Drug Promotion.

The two main alternatives are running compliance monitoring in-house with software such as qordata's Compliance Central, which gives teams real-time dashboards, automated risk scoring, and a remediation workflow they own directly, or outsourcing it primarily as a managed consulting service performed on the company's behalf by a larger provider.